{
    "again, edit the data before saving if you want to": {
        "filled_form": {
            "hardware_4": "illumina hiseq 4000",
            "organism_part_5": "colon",
            "experimental_designs_10": "genotype design",
            "assay_by_molecule_14": "dna assay",
            "study_type_18": "rna-seq of coding rna from single cells"
        },
        "context": {
            "hardware_4": "Review  Actions  Search in PubMed  Search in NLM Catalog  Add to Search  . 2017 Jan;241(2):183-191.  doi: 10.1002/path.4821. Epub 2016 Nov 18.  Measuring cancer evolution from the genome  Trevor A Graham 1 , Andrea Sottoriva 2  Affiliations  Affiliations  1 Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK.\n...\n2 Cancer Evolutionary Genomics and Modelling Laboratory, Centre for Evolution and Cancer, The Institute of Cancer Research, Sutton, UK.  PMID: 27741350  DOI: 10.1002/path.4821  Item in Clipboard  Review  Measuring cancer evolution from the genome  Trevor A Graham et al. J Pathol. 2017 Jan.  Display options  Format  Actions  Search in PubMed  Search in NLM Catalog  Add to Search  . 2017 Jan;241(2):183-191.  doi: 10.1002/path.4821. Epub 2016 Nov 18.  Authors\n...\nAdd to Search  . 2017 Jan;241(2):183-191.  doi: 10.1002/path.4821. Epub 2016 Nov 18.  Authors  Trevor A Graham 1 , Andrea Sottoriva 2  Affiliations  1 Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK.  2 Cancer Evolutionary Genomics and Modelling Laboratory, Centre for Evolution and Cancer, The Institute of Cancer Research, Sutton, UK.  PMID: 27741350  DOI: 10.1002/path.4821  Item in Clipboard  Display options  Format  \n...\nCancer's second genome: Microbial cancer diagnostics and redefining clonal evolution as a multispecies process: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution.\n...\nTumor evolution: Linear, branching, neutral or punctuated?  Davis A, Gao R, Navin N. Davis A, et al. Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):151-161. doi: 10.1016/j.bbcan.2017.01.003. Epub 2017 Jan 19. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28110020 Free PMC article. Review.  See all similar articles  Cited by  Quantification of rare somatic single nucleotide variants by droplet digital PCR using SuperSelective primers.",
            "organism_part_5": "Pablo-Fontecha V, Hern\u00e1ndez-Ill\u00e1n E, Reparaz A, Asensio E, Morata J, Tonda R, Lahoz S, Parra C, Lozano JJ, Garc\u00eda-Heredia A, Mart\u00ednez-Roca A, Beltran S, Balaguer F, Jover R, Castells A, Trull\u00e0s R, Podlesniy P, Camps J. Pablo-Fontecha V, et al. Sci Rep. 2023 Nov 3;13(1):18997. doi: 10.1038/s41598-023-39874-0. Sci Rep. 2023. PMID: 37923774 Free PMC article.  Unraveling the Drivers of Tumorigenesis in the Context of Evolution: Theoretical Models and Bioinformatics Tools.\n...\nKeywords: clonal evolution of cancer; gradualism; hopeful monsters; intratumour heterogeneity; neutral evolution; next-generation sequencing; punctuated equilibrium; saltation; selection; subclones.  Copyright \u00a9 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.  PubMed Disclaimer  Similar articles  New paradigms in clonal evolution: punctuated equilibrium in cancer.\n...\nBowes AL, Tarabichi M, Pillay N, Van Loo P. Bowes AL, et al. J Pathol. 2022 Jul;257(4):466-478. doi: 10.1002/path.5914. Epub 2022 May 23. J Pathol. 2022. PMID: 35438189 Free PMC article. Review.\n...\nZhu X, Zhao W, Zhou Z, Gu X. Zhu X, et al. J Mol Evol. 2023 Aug;91(4):405-423. doi: 10.1007/s00239-023-10117-0. Epub 2023 May 29. J Mol Evol. 2023. PMID: 37246992 Review.  The role of PIK3CA gene mutations in colorectal cancer and the selection of treatment strategies.  Wang H, Tang R, Jiang L, Jia Y. Wang H, et al. Front Pharmacol. 2024 Oct 30;15:1494802. doi: 10.3389/fphar.2024.1494802. eCollection 2024. Front Pharmacol. 2024. PMID: 39555098 Free PMC article. Review.\n...\nby virtue of ongoing mutations that uniquely mark clonal lineages within the tumour, provides a rich, yet surreptitious, record of cancer development. In this review, we describe how a cancer's genome can be analysed to reveal the temporal history of mutation and selection, and discuss why both selective and neutral evolution feature prominently in carcinogenesis. We argue that selection in cancer can only be properly studied once we have some understanding of what the absence of selection",
            "experimental_designs_10": "the relationship between genotype change and phenotype change. Copyright \u00a9 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.\n...\nTumor evolution: Linear, branching, neutral or punctuated?  Davis A, Gao R, Navin N. Davis A, et al. Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):151-161. doi: 10.1016/j.bbcan.2017.01.003. Epub 2017 Jan 19. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28110020 Free PMC article. Review.  See all similar articles  Cited by  Quantification of rare somatic single nucleotide variants by droplet digital PCR using SuperSelective primers.\n...\ncan only be properly studied once we have some understanding of what the absence of selection looks like. We review the data describing punctuated evolution in cancer, and reason that punctuated phenotype evolution is consistent with both gradual and punctuated genome evolution. We conclude that, to map and predict evolutionary trajectories during carcinogenesis, it is critical to better understand the relationship between genotype change and phenotype change. Copyright \u00a9 2016 Pathological\n...\nAdd to Search  . 2017 Jan;241(2):183-191.  doi: 10.1002/path.4821. Epub 2016 Nov 18.  Authors  Trevor A Graham 1 , Andrea Sottoriva 2  Affiliations  1 Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK.  2 Cancer Evolutionary Genomics and Modelling Laboratory, Centre for Evolution and Cancer, The Institute of Cancer Research, Sutton, UK.  PMID: 27741350  DOI: 10.1002/path.4821  Item in Clipboard  Display options  Format  \n...\nCancer's second genome: Microbial cancer diagnostics and redefining clonal evolution as a multispecies process: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution.",
            "assay_by_molecule_14": "Review  Actions  Search in PubMed  Search in NLM Catalog  Add to Search  . 2017 Jan;241(2):183-191.  doi: 10.1002/path.4821. Epub 2016 Nov 18.  Measuring cancer evolution from the genome  Trevor A Graham 1 , Andrea Sottoriva 2  Affiliations  Affiliations  1 Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK.\n...\nTumor evolution: Linear, branching, neutral or punctuated?  Davis A, Gao R, Navin N. Davis A, et al. Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):151-161. doi: 10.1016/j.bbcan.2017.01.003. Epub 2017 Jan 19. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28110020 Free PMC article. Review.  See all similar articles  Cited by  Quantification of rare somatic single nucleotide variants by droplet digital PCR using SuperSelective primers.\n...\nAdd to Search  . 2017 Jan;241(2):183-191.  doi: 10.1002/path.4821. Epub 2016 Nov 18.  Authors  Trevor A Graham 1 , Andrea Sottoriva 2  Affiliations  1 Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK.  2 Cancer Evolutionary Genomics and Modelling Laboratory, Centre for Evolution and Cancer, The Institute of Cancer Research, Sutton, UK.  PMID: 27741350  DOI: 10.1002/path.4821  Item in Clipboard  Display options  Format  \n...\n2 Cancer Evolutionary Genomics and Modelling Laboratory, Centre for Evolution and Cancer, The Institute of Cancer Research, Sutton, UK.  PMID: 27741350  DOI: 10.1002/path.4821  Item in Clipboard  Review  Measuring cancer evolution from the genome  Trevor A Graham et al. J Pathol. 2017 Jan.  Display options  Format  Actions  Search in PubMed  Search in NLM Catalog  Add to Search  . 2017 Jan;241(2):183-191.  doi: 10.1002/path.4821. Epub 2016 Nov 18.  Authors\n...\nSearch in MeSH  Add to Search  Actions  Search in PubMed  Search in MeSH  Add to Search  Related information  MedGen  Grants and funding  19771/CRUK_/Cancer Research UK/United Kingdom  LinkOut - more resources  Full Text Sources  Ovid Technologies, Inc.  Wiley  Other Literature Sources  scite Smart Citations",
            "study_type_18": "Similar articles  New paradigms in clonal evolution: punctuated equilibrium in cancer.  Cross WCh, Graham TA, Wright NA. Cross WCh, et al. J Pathol. 2016 Oct;240(2):126-36. doi: 10.1002/path.4757. Epub 2016 Aug 24. J Pathol. 2016. PMID: 27282810 Review.  Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers.\n...\nTumor evolution: Linear, branching, neutral or punctuated?  Davis A, Gao R, Navin N. Davis A, et al. Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):151-161. doi: 10.1016/j.bbcan.2017.01.003. Epub 2017 Jan 19. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28110020 Free PMC article. Review.  See all similar articles  Cited by  Quantification of rare somatic single nucleotide variants by droplet digital PCR using SuperSelective primers.\n...\n2 Cancer Evolutionary Genomics and Modelling Laboratory, Centre for Evolution and Cancer, The Institute of Cancer Research, Sutton, UK.  PMID: 27741350  DOI: 10.1002/path.4821  Item in Clipboard  Review  Measuring cancer evolution from the genome  Trevor A Graham et al. J Pathol. 2017 Jan.  Display options  Format  Actions  Search in PubMed  Search in NLM Catalog  Add to Search  . 2017 Jan;241(2):183-191.  doi: 10.1002/path.4821. Epub 2016 Nov 18.  Authors\n...\nCancer's second genome: Microbial cancer diagnostics and redefining clonal evolution as a multispecies process: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution.\n...\nAdd to Search  . 2017 Jan;241(2):183-191.  doi: 10.1002/path.4821. Epub 2016 Nov 18.  Authors  Trevor A Graham 1 , Andrea Sottoriva 2  Affiliations  1 Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK.  2 Cancer Evolutionary Genomics and Modelling Laboratory, Centre for Evolution and Cancer, The Institute of Cancer Research, Sutton, UK.  PMID: 27741350  DOI: 10.1002/path.4821  Item in Clipboard  Display options  Format  "
        }
    }
}